[go: up one dir, main page]

MX2022009115A - Composiciones para eliminar tejidos necroticos o infectados de lesiones de la superficie corporal. - Google Patents

Composiciones para eliminar tejidos necroticos o infectados de lesiones de la superficie corporal.

Info

Publication number
MX2022009115A
MX2022009115A MX2022009115A MX2022009115A MX2022009115A MX 2022009115 A MX2022009115 A MX 2022009115A MX 2022009115 A MX2022009115 A MX 2022009115A MX 2022009115 A MX2022009115 A MX 2022009115A MX 2022009115 A MX2022009115 A MX 2022009115A
Authority
MX
Mexico
Prior art keywords
compositions
infected tissues
body surface
surface lesions
remove necrotic
Prior art date
Application number
MX2022009115A
Other languages
English (en)
Inventor
Carlo Alberto Bignozzi
Alberto Cogo
Bertus Jozef Quint
Original Assignee
Debx Medical Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debx Medical Holding B V filed Critical Debx Medical Holding B V
Publication of MX2022009115A publication Critical patent/MX2022009115A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición utilizable para eliminar una biopelícula y tejidos necróticos o infectados de una lesión cutánea, la cual comprende ácido etanosulfónico o ácido 1-propanosulfónico y un aceptor de protones. El aceptor de protones se selecciona del grupo que consiste en: sulfóxido de dimetilo, dióxido de silicio, tetraetoxisilano y mezclas de los mismos. Dicha composición se puede preparar en forma de gel.
MX2022009115A 2020-01-23 2020-01-23 Composiciones para eliminar tejidos necroticos o infectados de lesiones de la superficie corporal. MX2022009115A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2020/051652 WO2021148124A1 (en) 2020-01-23 2020-01-23 Compositions for removing necrotic or infected tissues from body surface lesions

Publications (1)

Publication Number Publication Date
MX2022009115A true MX2022009115A (es) 2022-08-18

Family

ID=69232840

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009115A MX2022009115A (es) 2020-01-23 2020-01-23 Composiciones para eliminar tejidos necroticos o infectados de lesiones de la superficie corporal.

Country Status (16)

Country Link
US (1) US20230048954A1 (es)
EP (1) EP4093390B1 (es)
JP (1) JP7528227B2 (es)
KR (1) KR20220131967A (es)
CN (1) CN115003292A (es)
AR (1) AR121104A1 (es)
AU (1) AU2020424270A1 (es)
BR (1) BR112022014452A2 (es)
CA (1) CA3164588A1 (es)
CO (1) CO2022011859A2 (es)
IL (1) IL294827A (es)
MX (1) MX2022009115A (es)
PH (1) PH12022551835A1 (es)
SA (1) SA522433356B1 (es)
TW (1) TWI882063B (es)
WO (1) WO2021148124A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2730934A1 (fr) * 1995-02-23 1996-08-30 Oreal Utilisation des acides sulfoniques comme agents bactericides dans une composition cosmetique ou dermatologique
JP3657869B2 (ja) 1999-10-29 2005-06-08 株式会社巴川製紙所 低反射部材
WO2014177530A1 (en) * 2013-05-03 2014-11-06 Basf Se Synergistic antimicrobial formulation
US20150342912A1 (en) * 2014-06-02 2015-12-03 Epien Medical, Inc. Method and formulation for treating mucosal discontinuities and for reducing biofilms
US20160058718A1 (en) * 2014-09-02 2016-03-03 Michael Basara Formulation and method of treating chronic wounds and preventing bacterial infections
JP6375043B1 (ja) 2017-10-31 2018-08-15 日本パーカライジング株式会社 前処理剤、前処理方法、化成皮膜を有する金属材料およびその製造方法、並びに塗装金属材料およびその製造方法
KR102696528B1 (ko) 2018-04-04 2024-08-19 바스프 에스이 TiN 을 포함하는 층 또는 마스크의 에싱 후 잔류물 제거 및/또는 산화 에칭을 위한 이미다졸리딘티온-함유 조성물

Also Published As

Publication number Publication date
CN115003292A (zh) 2022-09-02
TW202139985A (zh) 2021-11-01
TWI882063B (zh) 2025-05-01
US20230048954A1 (en) 2023-02-16
EP4093390B1 (en) 2025-05-07
SA522433356B1 (ar) 2024-05-13
AU2020424270A1 (en) 2022-08-18
CO2022011859A2 (es) 2022-08-30
JP7528227B2 (ja) 2024-08-05
CA3164588A1 (en) 2021-07-29
WO2021148124A1 (en) 2021-07-29
JP2023519079A (ja) 2023-05-10
EP4093390A1 (en) 2022-11-30
AU2020424270A2 (en) 2022-10-27
PH12022551835A1 (en) 2024-01-22
BR112022014452A2 (pt) 2022-09-13
IL294827A (en) 2022-09-01
KR20220131967A (ko) 2022-09-29
EP4093390C0 (en) 2025-05-07
AR121104A1 (es) 2022-04-20

Similar Documents

Publication Publication Date Title
JP5203955B2 (ja) アミノ酸とヒアルロン酸ナトリウムを基にしたクリーム剤の形態の創傷治癒医薬組成物
PT2211919E (pt) Composições à base de gel de silicone para cicatrização de ferimentos e redução de cicatriz
BRPI0911541A2 (pt) composição para tratamento dos cabelos para prevenção de danos por oxidação ao cabelo, métodos de, e método de comercialização de tais composições
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
RU2019118896A (ru) Композиции для ухода за полостью рта и способы отбеливания зубов
AR037556A1 (es) Composicion farmaceutica que comprende un abridor del canal de c1c-2
FR2870739A1 (fr) Utilisation du lif en cosmetique et en dermatologie
FR3035790A3 (fr) Preparation dentaire a base d'hyaluronane et de dichlorhydrate d'octenidine
WO2014030992A2 (es) Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné
MX2022009115A (es) Composiciones para eliminar tejidos necroticos o infectados de lesiones de la superficie corporal.
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
CN103876983A (zh) 酵素酶牙膏
US20200000918A1 (en) Cosmetic and pharmaceutical agents for treating wounds and/or hemorrhaging of the skin, mucous membranes or the gum, in particular, for example, superficial cracks (rhagades) or periodontitis
ES2623888T3 (es) Composiciones de descamación que comprenden ácido tricloroacético (TCA) y fenol para reducir el dolor quemante causado por la descamación con TCA
JP2009513587A (ja) アミノ酸とヒアルロン酸ナトリウムを基にした滅菌粉末の形態の創傷治癒医薬組成物
BR112023023455A2 (pt) Composições para tratamento bucal que compreendem copolímero em bloco
US1513233A (en) Cuticle and nail salve
PH12021552179A1 (en) Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity
MX2022013857A (es) Composiciones que comprenden tropoelastina reticulada con ácido hialurónico y métodos de uso de estas.
ATE437628T1 (de) Reizlinderndes hustenmittel enthaltend extrakte aus isländischem moos und malve sowie zinkverbindungen
ES3047058T3 (en) Cosmetic composition of non-aqueous thixotropic nail varnish containing a nail-hardening agent, use and implementation method
BR112022007813A2 (pt) Composições farmacêuticas para uso na melhoria, prevenção ou tratamento de uma condição inflamatória e para uso no tratamento da dor associada a uma condição inflamatória, métodos para melhorar, prevenir ou tratar uma condição inflamatória e para tratar a dor associada a uma condição inflamatória, e, composição farmacêutica anti-inflamatória
AR134044A1 (es) Composiciones alisadoras del cabello y métodos de utilización de las mismas
MX2024007301A (es) Peptidos y metodos para usar en el tratamiento del dolor.
EA200800896A1 (ru) Композиция с высокой осмотической активностью антимикробного, противовоспалительного и регенерационного действия